CDMRP Funding for Startups: Eligibility, Pre-Applications, and Review

How CDMRP funding fits a startup’s research strategy

The Department of Defense’s Congressionally Directed Medical Research Programs, or CDMRP, funds research addressing specific diseases, injuries, and health challenges. For a US biotech, diagnostics, medical device, or digital health startup, it can provide a route to support a defined research project when an available funding opportunity matches the company’s science. Programs have supported areas including breast cancer, prostate cancer, traumatic brain injury, and spinal cord injury. Congress determines funding through annual appropriations, so the available programs, research priorities, and award mechanisms can change between funding cycles.

CDMRP opportunities operate separately from SBIR and STTR. Each program announcement defines eligible organizations, investigator qualifications, scientific priorities, funding limits, and the expected maturity of the research. Many opportunities permit applications from for-profit organizations, allowing companies to compete alongside universities, hospitals, and other research institutions. A startup’s strongest entry point is a project that directly addresses the announcement’s stated need and fits the selected award mechanism. Begin on the official CDMRP funding opportunities page, then read the complete announcement and its associated application instructions before assigning a team to prepare the submission.

Match the award mechanism to your evidence and next milestone

CDMRP programs use award mechanisms designed for different stages and purposes. Depending on the program and year, opportunities may support exploratory ideas, development of an established research concept, translational work, or clinical investigation. Mechanism names and requirements vary across programs. An early-stage mechanism may emphasize a high-impact hypothesis and limit the role of preliminary data; a translational mechanism may expect substantial supporting evidence and a clear path toward clinical application. Clinical trial opportunities carry additional requirements involving study design, regulatory readiness, patient access, and oversight. Read the eligibility and research scope provisions for the specific mechanism you are considering.

Build a short fit assessment that identifies the required focus area, your supporting evidence, the proposed milestone, the intended patient population, and the resources needed to complete the work. For example, a startup developing a blood-based assay should determine whether the opportunity supports biomarker discovery, analytical validation, clinical validation, or another defined activity. Those stages require different samples, endpoints, and expertise. Also check whether the announcement requires relevance to Service Members, Veterans, military families, or a broader disease population. Where military relevance is requested, explain the actual use setting and clinical need with evidence appropriate to the project.

Funding limits require equally careful reading. CDMRP announcements may cap direct costs or total costs, and some mechanisms offer different funding levels for different project types or partnership structures. A direct-cost ceiling leaves room for allowable indirect costs according to the announcement’s rules; a total-cost ceiling includes them. Record the maximum performance period, budget basis, permitted clinical activities, and any required collaborators in the same fit assessment. This gives the founder and research director a practical decision document before they commit to application development.

Navigate the pre-application through eBRAP

CDMRP generally uses the Electronic Biomedical Research Application Portal, known as eBRAP, for pre-applications. The announcement specifies whether this stage requires a letter of intent or a competitive preproposal. A letter of intent typically provides advance information about the planned submission. A preproposal may undergo screening that determines which applicants receive invitations to submit a full application. These routes have different implications for your schedule: an invitation-based mechanism creates a selection decision before the full proposal, while a letter-of-intent route generally allows eligible applicants to proceed according to the announcement’s instructions.

Prepare the pre-application around the information requested for that mechanism, which may include a research summary, impact statement, personnel, partnering organizations, and supporting documentation. Treat a screened preproposal as a complete scientific argument within its page limit. State the problem, the proposed advance, the key evidence, and the result the funded work would deliver. Check investigator eligibility carefully because some mechanisms restrict career stage or require particular experience or partnerships. Record the pre-application deadline, any invitation requirements, and the full-application deadline as separate milestones, including the specified time zone.

Assemble and verify the full application

For extramural applicants such as startups, full applications are generally submitted through Grants.gov, following the program announcement and CDMRP’s General Application Instructions. eBRAP supports additional application tracking and verification functions. Your company should establish the required organizational registrations and submission authority well before the deadline, including an active SAM.gov registration and Unique Entity ID. Confirm that the person responsible for submission has the necessary Grants.gov role and that the investigator and organizational information are entered consistently. Registration, internal approval, submission, and application verification each need an owner on the company’s calendar.

The full application usually extends well beyond a research narrative. Depending on the mechanism, required materials can include technical and public abstracts, biosketches, budget justification, facilities information, collaboration documents, and plans addressing human subjects or animal research. CDMRP opportunities may also require specific impact, innovation, military relevance, or transition statements. Use the announcement’s attachment list as your production checklist. For work involving patients, clinical samples, or regulated products, explain access to the necessary resources and the approvals that affect project timing. Applicable DoD research oversight can create additional requirements beyond your institution’s local review process.

After submission, review the Grants.gov status and follow the applicable eBRAP verification instructions. Check that files are complete, readable, and associated with the correct application. Observe the announcement’s rules for corrections and the application verification deadline; the verification process has a defined scope and schedule. Build an internal submission target early enough to address technical errors while the permitted submission or correction window remains open. A successful electronic transmission and a complete, compliant application are separate checkpoints that both deserve documented review.

Write for scientific peer review and programmatic review

CDMRP uses a two-tier review process: scientific peer review followed by programmatic review. Peer review evaluates the application against criteria specified in the announcement, which may include research strategy, feasibility, impact, innovation, personnel, and resources. Consumer reviewers can contribute perspectives informed by lived experience with the disease or condition. Programmatic review then considers scientific merit alongside factors such as relevance to program priorities and the balance of the research portfolio. A strong application therefore makes both its technical case and its value to the program easy to identify.

For a startup, this means connecting rigorous experiments to a meaningful development decision. Define measurable endpoints, explain sample-size assumptions where appropriate, identify major risks, and describe feasible alternatives. Show how the resulting evidence could advance a diagnostic, therapeutic, device, or care approach toward practical use. Keep commercial projections proportionate to the mechanism’s objectives and give reviewers a clear account of the company’s ability to execute the work. To assess your project’s eligibility, mechanism fit, and application readiness, book a free eligibility call with GrantUp.